Table 5.

Correlation Between CGH Gains and High-Level DNA Amplifications and Gene Amplifications by Southern Blot

Chromosomal Region Gene ExaminedCases Studied Gene Amplification/Gain5-150
CGH Amplification CGH Gain CGH Normal
2pter N-MYC  12  0/2  0/1  0/9  
3qter  BCL6  30 0/6  0/13  0/11  
8qter  C-MYC  34  1/2  0/4 0/28  
10p12-p13  BMI-1   9  2/2  —  0/7 
12q13  CKD4  18  —  5/6  0/12  
18qter  BCL2 18  0/4  0/4  0/10 
Chromosomal Region Gene ExaminedCases Studied Gene Amplification/Gain5-150
CGH Amplification CGH Gain CGH Normal
2pter N-MYC  12  0/2  0/1  0/9  
3qter  BCL6  30 0/6  0/13  0/11  
8qter  C-MYC  34  1/2  0/4 0/28  
10p12-p13  BMI-1   9  2/2  —  0/7 
12q13  CKD4  18  —  5/6  0/12  
18qter  BCL2 18  0/4  0/4  0/10 
F5-150

Number of tumors with gene amplification or gains/number of tumors examined by Southern blot. Not all cases examined by CGH could be analyzed molecularly.

Close Modal

or Create an Account

Close Modal
Close Modal